Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Rande Is who wrote (31307)	8/5/2000 8:25:25 AM
From: kendall harmon	Respond to of 57584

IVX good article from Miami here <<Ivax to buy fast-growing Wakefield Shares fall on rumors FDA won't approve drug BY MICHELE CHANDLER mchandler@herald.com Laying the groundwork for the upcoming sale of its asthma medications in the United States, Miami pharmaceutical company Ivax Corp. will buy fast-growing Wakefield Pharmaceuticals of Alpharetta, Ga., for an undisclosed sum. Wakefield sells respiratory products to physicians and was ranked among the 500 fastest growing companies by Inc. magazine last year. The all-stock purchase will add slightly to Ivax's earnings, said company vice chairman Neil Flanzraich. Even with that news, Ivax's stock price -- which has soared more than fourfold since January -- tumbled Friday on industry rumors that the Food and Drug Administration will not approve Ivax's generic version of an anti-cancer drug made by pharmaceutical giant Bristol-Myers Squibb. Ivax shares fell $4 Friday to close at $45.75. Wall Street analysts said Flanzraich called them personally to dispel the rumors. Ivax executives have high hopes for their generic version of the brand-name drug Taxol, which is Bristol-Myers' second-biggest-selling medication, with sales of $2 billion expected this year. The drug is approved in the United States for treatment of ovarian cancer, breast cancer, lung cancer and for an AIDS-related cancer known as Kaposi's sarcoma. Flanzraich called analysts to tell them ``what he was hearing, and that it was untrue,'' said Edward Tavlin, who follows Ivax for the investment firm of Fahnestock & Co. in Hallandale. Tavlin -- who had not heard the rumor before Flanzraich's telephone call -- said short sellers, who bet on stock prices to fall, may have initiated the rumors. ``I see no reason for the FDA to turn the drug down. It has been approved in other countries,'' Tavlin said. Bristol-Myers, which filed an unsuccessful patent challenge to block Ivax's drug, would not have put up such a ferocious fight ``if there was any question about the drug's efficacy,'' Tavlin said. ``But you can scare the daylights out of the market, and that's what happened.'' Said Flanzraich: ``I'm sure it will blow away and we will recover.'' He said Ivax expects the drug to be approved soon, he said. The company's asthma drugs, meanwhile, are not expected to be approved for about two years. But Ivax's purchase of Wakefield will give the company time to integrate operations. Wakefield's 50-member sales force, which now sells Wakefield's respiratory products, will begin selling Ivax's brand name asthma products. The first product is expected to receive U.S. approval in late 2002 or early 2003, Flanzraich said. Ivax's asthma products are already strong sellers in Europe. In June, Ivax acquired Venezuela's Laboratorios Elmor, a Caracas firm that develops and sells a broad range of medicines. >> herald.com

To: Rande Is who wrote (31307)	8/5/2000 10:45:38 AM
From: Bruce Denney	Respond to of 57584

Rande Is...just wanted to give a heads up to your thread re:alan ablesons comments today...another negative article aimed at Q and its cousins. enjoy reading your thread bad

To: Rande Is who wrote (31307)	8/5/2000 12:15:48 PM
From: carepedeum2000	Read Replies (1) \| Respond to of 57584

rande- you sure have a knack of verbalizing in writing much more clearly what im thinking, i am on the same page as you 100%, thanks for the "chystalization", i still think the battleground of 3900-4000 is critical and will not fall easily, also, i think cisco's earnings may proove to be a bigger catalyst for the market next week than the ppi/cpi numbers, anyway, its the weekend, spirit- want to talk politics? (just kidding, just kidding) I'd rather be golfing

To: Rande Is who wrote (31307)	8/5/2000 7:18:22 PM
From: shadowman	Read Replies (1) \| Respond to of 57584

A good weekend read from Kevin (he put some work into this) on the Angels thread. I'd be interested in reading Rande's take on Kevin's prognostication. Message 14169729

To: Rande Is who wrote (31307)	8/5/2000 9:08:41 PM
From: American Spirit	Read Replies (1) \| Respond to of 57584

Rande, I am intrigued with the takeover candidates UIS, LOR, NOVL and IFMX now (all of which I own). Each one has hundreds of millions in cash and market caps only 5 or so times higher. Add other assets and major future potential performance and all four should be attracting enormous takeover interest. All speculation of course but I would be surprised if one or more of them get taken out soon. I also see little or no downside in any of them. In other words at these prices I feel you'll always be able to get your money back even if they dip for a little while. ESHR is another amazing bargain. Market cap now only 80 million. True ESHR's more of a start-up and isn't profitable yet but it's down to 4 from 25 and I just doubled up on it. They have a big deal with Walmart they haven't even announced yet for some reason. Someday these type B2B's should come back into some favor. LU is one I bought Friday. I tyhink the selling is way overdone. Down to a reasonable PE and the market is discounting it's gargantuan potential to dominate, similar to IBM in that way. The market is assuming modest growth but both LU and IBM I think could ratchet it up considerably soon enough. Both most trusted names in their sectors for one thing. IBM exec I rode in 1st class with last month said they're overflowing with service orders. Which also makes IBM a probable buyer of some of the smaller beaten-down firms - like UIS, IFMX and NOVL. We come full circle.

To: Rande Is who wrote (31307)	8/6/2000 1:34:51 AM
From: Jorj X Mckie	Read Replies (1) \| Respond to of 57584

Rande Is, Congratulations on winning the SI Choice MVP award. JXM

To: Rande Is who wrote (31307)	8/6/2000 1:37:02 AM
From: redwood	Respond to of 57584

Rande is...MVP.....the most important award...congrats

To: Rande Is who wrote (31307)	8/6/2000 2:13:00 AM
From: Mark Konrad	Read Replies (1) \| Respond to of 57584

Congratulations, Rande! Well deserved--Mark--

To: Rande Is who wrote (31307)	8/6/2000 2:23:51 AM
From: Joe Lyddon	Respond to of 57584

C O N G R A T U L A T I O N S. . . MVP! We graciously await your acceptance speech! (we get good stuff every day!) Good job, Rande! Joe

To: Rande Is who wrote (31307)	8/6/2000 2:49:05 AM
From: Quiveringtrader	Read Replies (2) \| Respond to of 57584

Way to go Rande...Actually, there was never a doubt from the people who read and adhere to your advice. Tom L

To: Rande Is who wrote (31307)	8/6/2000 3:15:49 AM
From: Canuck Dave	Respond to of 57584

Let me add my congratulations as well, Rande. An award well deserved. CD

To: Rande Is who wrote (31307)	8/6/2000 10:13:17 AM
From: FritzV	Respond to of 57584

Rande, Congratulations on the MVP I've said it before and way it again.. You are one SPECIAL PERSON! Fritz

To: Rande Is who wrote (31307)	8/6/2000 11:54:20 AM
From: Kevin Shea	Respond to of 57584

I just HAD to say this -- if it doesn't pan out this way then i guess we will all be HORSE's ARSE's <VBG>

To: Rande Is who wrote (31307)	8/6/2000 2:22:42 PM
From: Joe Smith	Respond to of 57584

Being a bit of an ARSE myself, I have always assumed that the market would react ahead of time, but recent history has seemed to always disappoint me here. In fact, IMO the market has been quite timely. What may be happening here is that we have been anticipating a sell-off that is expected for the third week in August during the first week in August and it just has not happened yet. I urge caution. What may have happened last week was just some good old covering by shorts taking profits ( myself included). I am looking at some beaten down semi-conductor related stocks, especially CNXT and VTSS, but I am just dipping my feet in the water. Also happy to pick up a few rats that must be near their bottom. LOGC, FIVE, HEAR, LQID. Some recent examples of market timeliness. We all anticpated an earnings run in July. When it had not materialized in early July, many of us became impatient, but it did finally materialize exactly on time with YHOO's earnings. My buys a few days before the earnings announcement were early. My purchases that day were perfectly timed. The Spring sell-off ended with Memorial Day weekend, the traditional beginning of Summer. The tax-bite sell-off bottomed on tax day. The Winter rally topped out about a week before the Spring equinox. The Santa Claus rally topped out on 1/2. The October sell-off bottomed in the middle of October. All of these, right on time as if they followed a script IMO. So, if we follow suit, we will see a big sell-off right on time, the third week in August and not before then and we will all anticipate the next rally and it will stubbornly not appear until 9/5, the day after Labor Day, a rally that will stubbornly continue until October. Any thoughts? Rande, Mark, Kevin, Carp, Kal, DO? Am I just a step behind everyone as usual? EDIT: Hard to believe that the MM's will miss this chance to shake loose some cheap shares. Was Thursday morning the capitulation??? Not IMHO.